Adrian S. Ray - Sep 14, 2022 Form 3 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Chief Scientific Officer
Signature
/s/ Robert Ho, Attorney-in-Fact
Stock symbol
THRD
Transactions as of
Sep 14, 2022
Transactions value $
$0
Form type
3
Date filed
9/14/2022, 06:02 PM
Next filing
Oct 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRD Employee Stock Option (right to buy) Sep 14, 2022 Common Stock 310K $9.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 6.25% of the total shares vested on April 1, 2022, and thereafter 6.25% of the total shares underlying the award shall vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks:

No securities are beneficially owned.